BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15372065)

  • 1. The financial cost of optimising blood pressure control.
    Shiner T; Simons L; Parkinson H; Khanbhai A; Karthikeyan VJ; Nandhara G; Beevers DG
    J Hum Hypertens; 2005 Jan; 19(1):83-4. PubMed ID: 15372065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic view on affordability of fixed-dose combination antihypertensive drug therapy.
    Hong SH; Wang J; Tang J
    Am J Hypertens; 2013 Jul; 26(7):879-87. PubMed ID: 23512697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving cost-effectiveness of hypertension management at a community health centre.
    Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K
    S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prescription survey in a hospital hypertension outpatient clinic.
    Lee PK; Li RK; Chan JC; Chang S; Lee SC; Tomlinson B; Critchley JA
    Br J Clin Pharmacol; 1997 Dec; 44(6):577-82. PubMed ID: 9431835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of fixed dose antihypertensive drugs].
    García Ruiz AJ; Divisón Garrote JA; García-Agua Soler N; Morata García de la Puerta F; Montesinos Gálvez AC; Avila Lachica L
    Semergen; 2013 Mar; 39(2):77-84. PubMed ID: 23452532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
    Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
    Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of pharmacologic costs in the treatment of arterial hypertension. Approximation to a cost-effectiveness study].
    Alonso Moreno FJ; García Palencia M; Laborda Peralta M; Hermoso López A; Lopez de Castro F
    Aten Primaria; 1998 May; 21(9):607-12. PubMed ID: 9677744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit of treating hypertension.
    Jönsson BG
    J Hypertens Suppl; 1994 Dec; 12(10):S65-70. PubMed ID: 7769494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
    Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
    Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the patient group for cost-effective withdrawal of antihypertensive therapy.
    Krakoff LR; Wassertheil-Smoller S
    Pharmacoeconomics; 1995 Mar; 7(3):221-8. PubMed ID: 10155311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical economics of hypertension therapy].
    Yamazaki T
    Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
    [No Abstract]   [Full Text] [Related]  

  • 14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost effectiveness of combination therapy. Based on a presentation by Daniel Hilleman, PharmD.
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S449-53; discussion S453-5. PubMed ID: 10538853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators.
    Staessen JA; Byttebier G; Buntinx F; Celis H; O'Brien ET; Fagard R
    JAMA; 1997 Oct; 278(13):1065-72. PubMed ID: 9315764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The managed hypertensive: the costs of blood pressure control in a Nigerian town.
    Ilesanmi OS; Ige OK; Adebiyi AO
    Pan Afr Med J; 2012; 12():96. PubMed ID: 23133696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of hypertension treatment.
    Odell TW; Gregory MC
    J Gen Intern Med; 1995 Dec; 10(12):686-8. PubMed ID: 8770721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacoeconomic assessment of antihypertensive therapy for patients of elderly and senile age in the hospital for veterans of war].
    Hrinenko IuO; Kuprash LP
    Lik Sprava; 2010; (3-4):108-16. PubMed ID: 21265129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.